Prescriptions | n=10 652 213 | % |
Total new prescriptions for all medications* | 10 652 213 | 100 |
Medication subgroups | ||
Medication for chronic physical conditions† | 1 230 371 | 11.55 |
Analgesics (anilides and propionic acid derivatives) | 5 323 761 | 49.98 |
Penicillin | 1 258 577 | 11.82 |
PPIs | 1 293 904 | 12.15 |
Benzodiazepines | 950 890 | 8.93 |
SSRIs | 389 967 | 3.66 |
Other antiepileptics | 204 743 | 1.92 |
Patients | n=3 075 364 | % |
Gender (female) | 1 679 893 | 54.62 |
Age (mean±SD) | 50.61 | 18.90 |
Copayment grade | ||
Poor population (0%) | 205 006 | 6.67 |
Low-middle income pensioners (10%) | 962 622 | 31.30 |
Low-income non-pensioners (40%) | 1 349 222 | 43.87 |
Middle-income non-pensioners (50%) | 505 597 | 17.86 |
High-income population (60%) | 9271 | 0.30 |
Area socioeconomic status | ||
Urban 1 | 449 117 | 14.60 |
Urban 2 | 498 001 | 16.19 |
Urban 3 | 512 450 | 16.66 |
Urban 4 | 524 855 | 17.07 |
Urban 5 | 516 091 | 16.78 |
Rural | 574 772 | 18.69 |
Nationality | ||
Spaniard | 2 463 220 | 80.10 |
American | 250 906 | 8.16 |
Asian/Oceanian | 65 527 | 2.13 |
Other European | 123 248 | 4.01 |
African | 172 385 | 5.61 |
Active diseases† | ||
Allergy | 73 823 | 2.40 |
Pain | 1 086 049 | 35.32 |
Respiratory disease | 252 758 | 8.22 |
Disability | 506 422 | 16.47 |
Cardiovascular | 1 551 824 | 50.46 |
Mental disorder | 688 581 | 22.39 |
Neurological | 249 993 | 8.13 |
Diabetes mellitus | 302 175 | 9.83 |
Digestive system disorder | 392 931 | 12.78 |
Thyroid gland-related disease | 177 456 | 5.77 |
Number of grouped comorbidities (mean±SD) | 1.72 | 1.48 |
Family physician characteristics | n=10 936 | % |
Gender (female) | 7514 | 68.71 |
Age (mean±SD) | 42.95 | 10.29 |
Assigned FPs | 3767 | 34.45 |
Primary care centre characteristics | n=295 | % |
Teaching centre | 72 | 24.41 |
↵*All medications include (ATC code): insulins and analogues for injection; long-acting (A10AE); platelet aggregation inhibitors excluding heparin (B01AC); ACE inhibitors, plain (C09AA); HMG CoA reductase inhibitors (C10AA); adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics (R03AK); anticholinergics (R03BB); PPIs (A02BC); propionic acid derivatives (M01AE); anilides (N02BE); other antiepileptics (N03AX); selective serotonin reuptake inhibitors (N06AB); benzodiazepine derivatives (N05BA); and penicillin with extended spectrum (J01CA).
↵†Medication for chronic physical conditions includes: long-acting insulins and analogues for injection; platelet aggregation inhibitors excluding heparin; plain ACE inhibitors; HMG CoA reductase inhibitors; adrenergics in combination with corticosteroids or other drugs excluding anticholinergics; anticholinergics.
FP, family physician; PPI, proton pump inhibitor; SSRI, selective serotonin reuptake inhibitor.